-
Drug Science Research Group And London College Team Up To Advance MDMA-Assisted Therapy
Wednesday, September 4, 2024 - 4:45pm | 672Drug Science and University College London (UCL) announced a strategic partnership to advance research into MDMA-assisted psychotherapy. This collaboration aims to refine our understanding of how MDMA works in conjunction with psychotherapeutic treatments, addressing concerns that the "...
-
European Cannabis News: These Countries Prep For Legalization, UK Official Calls Pot As Harmful As Heroin
Wednesday, January 25, 2023 - 11:27am | 831Cannabis investors, industry stakeholders and activists are gearing up to embrace new cannabis opportunities on the horizon, with several European countries on the cusp of legalizing either recreational or medical marijuana. Let's scroll through recent market highlights and regulatory...
-
This Legal Psychoactive Mushroom Reduces Stress And Pain And Encourages Longevity, Expert Says
Thursday, October 6, 2022 - 10:20am | 1604This article was originally published in December 2021. Amanita Muscaria is an understudied species of psychoactive mushroom that’s as commonplace as it is misunderstood. The iconic red-capped, white-dotted toadstool represents the archetypal idea of a mushroom in most people’s minds,...
-
Canada-Based Project Solace Aims To Provide Access And Data On Medical Psilocybin
Thursday, July 28, 2022 - 10:04am | 577TheraPsil, a Canadian coalition for psilocybin therapy legalization, together with the U.K. independent foundation Drug Science, has launched Project Solace. The goal is to gather data to better inform patients about the development of regulated psilocybin products. That way it can document...
-
Project Twenty 21 Releases Findings: Cannabis Dramatically Improves Lives Of Patients With Debilitating Conditions
Wednesday, May 12, 2021 - 12:01pm | 447Project Twenty 21 has published its first findings in the accredited scientific journal Psychopharmacology. The project, poised to provide patients access to affordable medical cannabis treatment, was launched in 2019 at the Royal College of Psychiatrists in London. The UK's national medical...